Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 69

ОБЗОР2026 · pp. 59–66

Molecular and biological characteristics of tumor cells in testicular embryonal carcinoma explants

Introduction. Personalized treatment strategies for embryonal carcinoma, a germ cell tumor, are crucial due to the inherent heterogeneity of the tumor. Existing in vitro models inadequately reflect the native tumor microenvironment. Ex vivo organ culture (EVOC…

10.29296/24999490-2026-03-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 53–58

Modern anticoagulants in the treatment and prevention of thrombotic complications in patients with Hodgkin’s lymphoma

Introduction. Cancer patients have a high risk of developing venous thromboembolic complications, which worsen the outcomes of antitumor treatment and are the second leading cause of death after cancer progression. Objectives – to assess the effect of modern a…

10.29296/24999490-2026-03-07Details ↗
ОБЗОР2026 · pp. 57–64

Branched chain amino acid transaminases: structure, molecular and genetic aspects, functional and pathogenetic role

This review systematizes current data on branched-chain aminotransferases (BCATs). Their molecular structure, classification as fold type IV pyridoxal phosphate (PLP)-dependent enzymes, and catalytic features are discussed in detail. The differences between th…

10.29296/24999490-2026-02-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 52–56

Comparative analysis of Hsp27 and Hsp90 expression in high- and low-grade ovarian carcinoma cells

Introduction. Ovarian cancer is characterized by high mortality. Despite available diagnostic and therapeutic methods, patient survival remains unsatisfactory, especially for high-grade tumors, necessitating the exploration of new molecular targets. Heat shock…

10.29296/24999490-2026-02-07Details ↗
ОБЗОР2026 · pp. 73–79

Differences in the genetic landscape of primary gastric adenocarcinoma and its regional lymph node metastases

Introduction. Lymphogenous metastasis is a key stage in the progression of gastric cancer. The practice of personalized treatment has historically been based on histological and molecular analysis of the primary tumor, while the molecular-genetic landscape of …

10.29296/24999490-2026-01-09Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 10–21

Telemedicine screening and three-year follow-up of stress-associated autonomic dysfunction in students during university adaptation: clinical and digital risk stratification and personalized prevention

Background. University entry is accompanied by abrupt changes in social environment, lifestyle and cognitive load, which challenge stress-response systems, the autonomic nervous system (ANS), and immune-metabolic homeostasis. In Russian clinical practice, this…

10.29296/24999490-2026-01-02Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 70–78

Artificial intelligence in early diagnosis: integration of pre-nosological screening and personalized prevention of chronic non-communicable diseases

Introduction. Chronic non-communicable diseases (NCDs) account for 75% of global mortality, while traditional treatment paradigm demonstrates inability to contain epidemiological burden. Artificial intelligence (AI) technologies combined with telemedicine enab…

10.29296/24999490-2025-05-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 77–85

Is the progression of tuberculosis possible against the background of antitumor therapy for lung cancer? Results of an experimental study

Aim of the study. The possibility of using antitumor drugs against the background of active tuberculosis is an unresolved problem of modern medicine. The aim of the experimental study was to study the course of tuberculosis infection against the background of …

10.29296/24999490-2025-03-10Details ↗
ОБЗОР2025 · pp. 30–38

Molecular mechanisms of action of natural bioactive compounds in personalized medicine for the rehabilitation of cancer patients after chemo and radiation therapy

The purpose of the study. To analyze scientific data on the molecular targets and mechanisms of action of key natural bioactive substances used to support cancer patients after chemotherapy and radiation therapy in the framework of personalized medicine. Perso…

10.29296/24999490-2025-03-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 38–44

A METHOD FOR ANALYZING THE CONCENTRATION OF HEAT SHOCK PROTEIN 70 KDA IN SECTIONS OF BRAIN TISSUE OF TRANSGENIC MICE HSP70[IN] AND HSP70[EX] BY CLASSIFYING RAMAN SPECTRA

Introduction. Heat shock proteins (HSPs) are a group of highly prospective compounds that can be used in various branches of clinical medicine, such as neurology, pharmacology and oncology. Studying the content of these proteins in various parts of the brain o…

10.29296/24999490-2025-02-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 34–40

Efficacy of antitumor therapy schemes with carboplatin in an experimental model of lung carcinoma and drug-resistant tuberculosis

Introduction. Up to 20% of tuberculosis patients suffer from malignant neoplasms. In this case, the combination of both diseases in the lung is a particular problem. More than 60% of patients cannot complete combination therapy due to drug-resistant MBT. The a…

10.29296/24999490-2025-01-04Details ↗
ОБЗОР2025 · pp. 3–15

Prospects for the application of nanotechnology in the development of antitumor drugs

Introduction. Nanotechnology represents an innovative direction in cancer drug development, enabling the creation of effective drug delivery systems with enhanced therapeutic properties. Objective. To analyze the main types of nanoparticles used in oncology, e…

10.29296/24999490-2025-01-01Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 61–67

Pathomorphological analysis of salinomycin and nanodiamonds efficacy on Lewis lung carcinoma in mice

Relevance. The search for new antitumor drugs and their selective delivery directly to the tumor site is an important task of modern oncology. For these purposes, currently, the use of various nanoparticles as carriers of medicinal substances is of great impor…

10.29296/24999490-2024-06-07Details ↗
ОБЗОР2024 · pp. 40–51

Use of nanotechnology in the creation of targeted drugs for the treatment of oncological diseases

Objective. To analyze current advances in nanotechnology applications for the development of targeted drugs in oncology, including their mechanisms of action and clinical application prospects. Material and methods. A comprehensive analysis of scientific liter…

10.29296/24999490-2024-06-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 40–47

COMPARATIVE ANALYSIS OF THE DIAGNOSTIC ACCURACY OF ENDOSTATIN AND VEGF SERUM LEVELS IN PATIENTS WITH BONE SARCOMAS

Introduction. Angiogenesis regulators are of particular interest as new serum markers in cancer patients, since they reflect the intensity of tumor growth and metastasis. Currently, many works are dedicated to the study of vascular endothelial growth factor (V…

10.29296/24999490-2024-05-05Details ↗
ОБЗОР2024 · pp. 31–39

USING ARTIFICIAL INTELLIGENCE FOR BIOMARKER ANALYSIS IN CLINICAL DIAGNOSTICS

Introduction. Artificial intelligence (AI) technologies are becoming crucial in clinical diagnostics due to their ability to process and interpret large volumes of data. The implementation of AI for biomarker analysis opens new opportunities in personalized me…

10.29296/24999490-2024-05-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 21–28

BIOLOGICAL MODEL OF LUNG CANCER COMBINATION AND TUBERCULOSIS: DEVELOPMENT FOR PRECLINICAL STUDY OF RATIONAL COMBINATIONS OF TARGETED ANTITUMOR AND ANTITUBERCULOSIS THERAPY

Introduction. Lung cancer occupies a leading position in the structure of mortality from cancer. Chronic inflammation characteristic of tuberculosis increases the risk of lung cancer. Currently, more and more information is emerging confirming the cause-and-ef…

10.29296/24999490-2024-02-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 35–42

EFFECTIVENESS AND SAFETY OF CARBOPLATIN-CONTAINING ANTITUMOR THERAPY REGIMENS IN A MODEL OF COEXISTANCE OF LUNG CARCINOMA AND TUBERCULOSIS

Introduction. Treatment of the coexistent pathology of lung cancer and tuberculosis remains the prerogative of experimental research, since the optimal treatment strategy for the coexistence of these two diseases has not yet been developed. The purpose was to …

10.29296/24999490-2024-01-05Details ↗

Article search and quick navigation

Navigation